Revolution Medicines Inc. (RVMD)
NASDAQ: RVMD
· Real-Time Price · USD
36.02
-0.14 (-0.39%)
At close: Aug 21, 2025, 11:56 AM
Revolution Medicines Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 402.44M | 333.55M | 543.06M | 201.26M | 275.71M | 288.43M | 696.15M | 358.4M | 380.33M | 427.22M | 161.41M | 178.94M | 105.78M | 97.67M | 108.5M | 129.15M | 195.6M | 351.6M |
Short-Term Investments | 1.73B | 1.77B | 1.75B | 1.35B | 1.32B | 1.42B | 1.16B | 454.8M | 529.16M | 482.58M | 483.53M | 476.07M | 355.65M | 421.09M | 468.56M | 479.5M | 450.72M | 330M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 35.34M | 16.83M | 17.57M | 13.16M | 11.3M | 7.19M | 10.06M | 13.74M | 5.29M | 4.51M | 4.59M | 2.59M | 2.46M | 2.59M | 2.5M | 1.35M | 1.35M | 1.39M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | 1.25M | 309K | 2.51M | 4M | 4.67M | 4.94M | 5.62M | 5.38M | 5.93M | 7.41M | 6.53M | 7.56M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 39.27M | 31.91M | 38.33M | 29.66M | 34.02M | 25.66M | 25.07M | 10.96M | 10.09M | 8.96M | 10.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 2.18B | 2.13B | 2.33B | 1.58B | 1.62B | 1.73B | 1.88B | 824.47M | 922.09M | 922.75M | 660.18M | 675.11M | 483.05M | 534.34M | 589.77M | 623.54M | 661.01M | 697.4M |
Property-Plant & Equipment | 147.05M | 142.93M | 141.82M | 99.15M | 100.59M | 99.89M | 100.01M | 73.41M | 73.45M | 72.84M | 73.74M | 74.53M | 73.34M | 71.63M | 71.24M | 35.34M | 36.67M | 37.57M |
Goodwill & Intangibles | 70.74M | 71.01M | 71.28M | 71.55M | 71.81M | 72.08M | 72.35M | 72.61M | 72.88M | 73.15M | 73.42M | 73.68M | 73.95M | 74.22M | 74.48M | 74.75M | 75.02M | 75.29M |
Total Long-Term Assets | 253.13M | 230.77M | 230.67M | 183.86M | 183.71M | 179.16M | 182.42M | 159.76M | 151.62M | 150.5M | 151.75M | 150.8M | 149.76M | 148.43M | 148.22M | 111.44M | 113.03M | 114.25M |
Total Assets | 2.43B | 2.37B | 2.56B | 1.76B | 1.81B | 1.91B | 2.06B | 984.23M | 1.07B | 1.07B | 811.93M | 825.91M | 632.8M | 682.77M | 737.99M | 734.98M | 774.05M | 811.65M |
Account Payables | 56.76M | 47.51M | 54.43M | 24.46M | 29.32M | 32.38M | 61.79M | 29.63M | 29.78M | 19.91M | 21.31M | 24.38M | 14.07M | 14.17M | 14.06M | 10.49M | 10.44M | 9.65M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.43M | 4.46M | 9.69M | 9.69M | 11.43M | 12.36M | 12.66M | 8.34M | 9.96M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 22.19M | 14.1M | 31.36M | 20.36M | 15.39M | 10.54M | 27.51M | 13.31M | 9.51M | 6.24M | 13.79M | 9.41M | 7.2M | 4.53M | 10.16M | 6.44M | 4.82M | 3.34M |
Total Current Liabilities | 184.53M | 158.6M | 163.91M | 110.86M | 105.33M | 93.72M | 143.85M | 85.54M | 78.06M | 54.63M | 61.98M | 73.27M | 63.54M | 57.46M | 60.35M | 51.89M | 45.8M | 43.76M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 257.61M | 4.89M | 3.86M | 4.41M | 2.06M | 6.2M | 7.97M | 982K | 252K | 1.69M | 301K | 5.89M | 4.06M | 7.3M | 634K | 10.61M | 8.23M | 9.57M |
Total Long-Term Liabilities | 379.67M | 128.6M | 129.18M | 85.83M | 84.26M | 89.17M | 91.66M | 61.23M | 64.81M | 66.39M | 64.76M | 71.22M | 70.42M | 74.32M | 75.07M | 44.88M | 43.24M | 45.31M |
Total Liabilities | 564.2M | 287.2M | 293.1M | 196.69M | 189.59M | 182.9M | 235.51M | 146.77M | 142.87M | 121.03M | 126.74M | 144.49M | 133.96M | 131.78M | 135.42M | 96.77M | 89.04M | 89.07M |
Total Debt | 132.79M | 134.34M | 135.84M | 86.71M | 87.41M | 88.03M | 87.94M | 62.85M | 63.26M | 63.6M | 64.2M | 65.2M | 64.95M | 65.91M | 66.63M | 31.79M | 32.49M | 31.99M |
Common Stock | 18K | 18K | 18K | 16K | 16K | 16K | 16K | 11K | 11K | 11K | 9K | 9K | 8K | 8K | 8K | 8K | 8K | 8K |
Retained Earnings | -2.2B | -1.95B | -1.74B | -1.54B | -1.39B | -1.25B | -1.14B | -976.17M | -867.74M | -769.44M | -701.34M | -644.83M | -571.5M | -510.28M | -452.64M | -399.96M | -347.02M | -302.72M |
Comprehensive Income | 1.3M | 1.71M | 1.32M | 3.81M | -1.86M | -1.2M | 544K | -871K | -1.25M | -556K | -1.78M | -2.42M | -1.76M | -1.28M | -376K | -40K | 9K | 63K |
Shareholders Equity | 1.87B | 2.08B | 2.27B | 1.57B | 1.62B | 1.73B | 1.83B | 837.46M | 930.84M | 952.22M | 685.19M | 681.42M | 498.84M | 550.99M | 602.57M | 638.2M | 685.01M | 722.58M |
Total Investments | 1.73B | 1.77B | 1.75B | 1.35B | 1.32B | 1.42B | 1.16B | 454.8M | 529.16M | 482.58M | 483.53M | 476.07M | 355.65M | 421.09M | 468.56M | 479.5M | 450.72M | 330M |